SEARCH

SEARCH BY CITATION

References

  • 1
    Crile G Jr., Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg 1953; 138: 338.
  • 2
    Lindsay S. Carcinoma of the thyroid gland: a clinical and pathologic study of 293 patients at the University of California Hospital. Springfield, IL: Charles C. Thomas, 1960.
  • 3
    Chen KTK, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol 1977; 1: 12330.
  • 4
    Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985; 55: 80528.
  • 5
    Sobrinho-Simões M, Soares J, Carneiro F, Limbert E. Diffuse follicular variant of papillary carcinoma of the thyroid: report of eight cases of a distinct aggressive type of thyroid tumor. Surg Pathol 1990; 3: 189203.
  • 6
    Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. In: International histological classification of tumours, World Health Organization, No. 11. Berlin: Springer-Verlag, 1988.
  • 7
    Carcangiu ML, Zampi G, Rosai J. Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. Pathol Ann 1985; 20: 144.
  • 8
    Hapke MR, Dehner LP. The optically clear nucleus: a reliable sign of papillary carcinoma of the thyroid? Am J Surg Pathol 1979; 3: 318.
  • 9
    Chan JKC, Saw D. The grooved nucleus: a useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol 1986; 10: 6729.
  • 10
    Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987.
  • 11
    Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989; 63: 908911.
  • 12
    Albores-Saavedra J, Gould E, Vardaman C, Vuitch F. The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 1991; 22: 1195205.
  • 13
    Miller JM, Kini SR, Hamburger JI. The diagnosis of malignant follicular neoplasms of the thyroid by needle biopsy. Cancer 1985; 55: 28127.
  • 14
    Hugh JC, Duggan MA, Chang-Poon V. The fine-needle aspiration appearance of the follicular variant of thyroid papillary carcinoma: a report of three cases. Diagn Cytopathol 1988; 4: 196201.
  • 15
    DeGroot LJ, Kaplan EL. Second operations for ‘completion’ of thyroidectomy in treatment of differentiated thyroid cancer. Surgery 1991; 110: 93640.
  • 16
    Wax MK, Briant TDR. Completion thyroidectomy in the management of well-differentiated thyroid carcinoma. Otolaryngol Head Neck Surg 1992; 107: 638.
  • 17
    Shaha AR, DiMaio T, Webber C, Jaffe BM. Intraoperative decision making during thyroid surgery based on the results of perioperative needle biopsy and frozen section. Surgery 1990; 108: 96471.
  • 18
    Layfield LJ, Mohrmann RL, Kopald KH, Giuliano AE. Use of aspiration cytology and frozen section examination for management of benign and malignant thyroid nodules. Cancer 1991; 68: 1304.
  • 19
    Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987; 102: 108895.
  • 20
    Robinson PG, Gould EW, Albores-Saavedra J, Irvin GL. Comparative study between papillary thyroid carcinoma and its follicular variant. Mod Pathol 1991; 4: 33A.
  • 21
    LiVolsi VA. Papillary neoplasms of the thyroid: pathologic and prognostic features. Am J Clin Pathol 1992; 97: 42634.
  • 22
    Beierwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A. Survival time and ‘cure’ in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J Nucl Med 1982; 23: 5618.
  • 23
    Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli J-P, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986; 63: 9607.
  • 24
    Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987; 14: 31532.
  • 25
    Mazzaferri EL, de los Santos ET. Impact of 131I therapy in the management of well differentiated thyroid carcinoma. In: FeeWEJr., GoepfertH, JohnsME, StrongEW, WardPH, et al., editors. Head and neck cancer. Toronto: BC Decker, 1990: 17583.
  • 26
    Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985; 55: 794804.
  • 27
    Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T. Papillary and follicular thyroid cancer. Am J Med 1987; 83: 47988.
  • 28
    Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 54576.
  • 29
    Volpe R. The immunoregulatory disturbance in autoimmune thyroid disease. Autoimmunity 1988; 2: 5572.